Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tatyana N Belovezhets"'
Autor:
Sergey V Guselnikov, Tatyana N Belovezhets, Sergey V Kulemzin, Andrey A Gorchakov, Alexander V Taranin
Publikováno v:
BioTechniques, Vol 67, Iss 4, Pp 184-187 (2019)
Cloning VH and VL genes from individual antigen-specific B cells is an attractive approach for producing monoclonal antibodies of the desired specificity. Current RT-PCR protocols, however, result in the successful identification of VH and VL gene pa
Externí odkaz:
https://doaj.org/article/56d4dfdee4f743cb9a777b95dc095966
Autor:
Sergey V. Guselnikov, Konstantin O. Baranov, Sergey V. Kulemzin, Tatyana N. Belovezhets, Anton N. Chikaev, Svetlana V. Murasheva, Olga Y. Volkova, Ludmila V. Mechetina, Alexander M. Najakshin, Nikolai A. Chikaev, Pavel P. Solodkov, Maria V. Sergeeva, Alexander V. Smirnov, Irina A. Serova, Oleg L. Serov, Alexander G. Markhaev, Yulia V. Kononova, Alexander Y. Alekseev, Marina A. Gulyaeva, Daria M. Danilenko, Nariman R. Battulin, Alexander M. Shestopalov, Alexander V. Taranin
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The COVID-19 pandemic has uncovered the high genetic variability of the SARS-CoV-2 virus and its ability to evade the immune responses that were induced by earlier viral variants. Only a few monoclonal antibodies that have been reported to date are c
Externí odkaz:
https://doaj.org/article/6da10109f6fb4cc2aa3729d2219d4170
Autor:
Pavel P. Solodkov, Alexander M. Najakshin, Nikolai A. Chikaev, Sergey V. Kulemzin, Ludmila V. Mechetina, Konstantin O. Baranov, Sergey V. Guselnikov, Andrey A. Gorchakov, Tatyana N. Belovezhets, Anton N. Chikaev, Olga Y. Volkova, Alexander G. Markhaev, Yulia V. Kononova, Alexander Y. Alekseev, Marina A. Gulyaeva, Alexander M. Shestopalov, Alexander V. Taranin
Publikováno v:
Vaccines, Vol 12, Iss 2, p 129 (2024)
The emergence of SARS-CoV-2 mutant variants has posed a significant challenge to both the prevention and treatment of COVID-19 with anti-coronaviral neutralizing antibodies. The latest viral variants demonstrate pronounced resistance to the vast majo
Externí odkaz:
https://doaj.org/article/3f932639df4445969276ce69457f349c
Autor:
Sergey V. Kulemzin, Sergey V. Guselnikov, Boris G. Nekrasov, Svetlana V. Molodykh, Irina N. Kuvshinova, Svetlana V. Murasheva, Tatyana N. Belovezhets, Andrey A. Gorchakov, Anton N. Chikaev, Nikolai A. Chikaev, Olga Y. Volkova, Anna A. Yurina, Alexander M. Najakshin, Alexander V. Taranin
Publikováno v:
Vaccines, Vol 12, Iss 1, p 55 (2024)
SARS-CoV-2 has a relatively high mutation rate, with the frequent emergence of new variants of concern (VOCs). Each subsequent variant is more difficult to neutralize by the sera of vaccinated individuals and convalescents. Some decrease in neutraliz
Externí odkaz:
https://doaj.org/article/aad5822efb674e47a6cbbe12f6831599
Autor:
Sergey V. Kulemzin, Maria V. Sergeeva, Konstantin O. Baranov, Andrey A. Gorchakov, Sergey V. Guselnikov, Tatyana N. Belovezhets, Olga Yu. Volkova, Alexander M. Najakshin, Nikolai A. Chikaev, Daria M. Danilenko, Alexander V. Taranin
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 6; Pages: 895
Immune evasion of SARS-CoV-2 undermines current strategies tocounteract the pandemic, with the efficacy of therapeutic virus-neutralizing monoclonal antibodies (nAbs) being affected the most. In this work, we asked whether two previously identified h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f780e836ec21c1ca2477f0db4f0f02e1
Autor:
Maria G. Byazrova, Sergey V. Kulemzin, Ekaterina A. Astakhova, Tatyana N. Belovezhets, Grigory A. Efimov, Anton N. Chikaev, Ilya O. Kolotygin, Andrey A. Gorchakov, Alexander V. Taranin, Alexander V. Filatov
Publikováno v:
Frontiers in Immunology. 13
The development of effective vaccines against SARS-CoV-2 remains a global health priority. Despite extensive use, the effects of Sputnik V on B cell immunity need to be explored in detail. We performed comprehensive profiling of humoral and B cell re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c683c690c18f23c5526da61ac034a97
https://doi.org/10.3389/fimmu.2022.840707
https://doi.org/10.3389/fimmu.2022.840707
Autor:
Maria G, Byazrova, Sergey V, Kulemzin, Ekaterina A, Astakhova, Tatyana N, Belovezhets, Grigory A, Efimov, Anton N, Chikaev, Ilya O, Kolotygin, Andrey A, Gorchakov, Alexander V, Taranin, Alexander V, Filatov
Publikováno v:
Frontiers in immunology. 13
The development of effective vaccines against SARS-CoV-2 remains a global health priority. Despite extensive use, the effects of Sputnik V on B cell immunity need to be explored in detail. We performed comprehensive profiling of humoral and B cell re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9159656586380a78884cdecf7be0397d
https://pubmed.ncbi.nlm.nih.gov/35280987
https://pubmed.ncbi.nlm.nih.gov/35280987
Autor:
Alexander V. Taranin, Grigory A. Efimov, Ilya O. Kolotygin, Ekaterina A. Astakhova, Alexander Filatov, Andrey A. Gorchakov, S. Kulemzin, Anton N. Chikaev, Tatyana N. Belovezhets, Maria G. Byazrova
The development of effective vaccines against SARS-CoV-2 remains a global health priority. Despite extensive use, the effects of Sputnik V on B cell immunity need to be explored in detail. We show that B memory cell (MBC) and antibody responses to Sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d62d06c265d0f68d4a4b2d09f586905
https://doi.org/10.1101/2021.10.13.21264894
https://doi.org/10.1101/2021.10.13.21264894
Autor:
M. Ermakov, Olga A. Koval, A. Taranin, Andrey A. Gorchakov, Anna A. Nushtaeva, Tatyana N. Belovezhets, Anton N. Chikaev, Elena V. Kuligina, S. Kulemzin, Vladimir A. Richter, Olga Troitskaya, V. Subrakova, Mikhail Varlamov
Publikováno v:
Genes & Cells. 14:66-71
Adoptive T- and NK-cells transfer with chimeric antigenic receptors (CAR) is considered as a promising anticancer strategy. Chimeric antigenic receptors are artificial molecules that provide activation of the cells carrying them when they contact wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a63f285c372e2a216874dfc9b708a13
https://doi.org/10.23868/201912034
https://doi.org/10.23868/201912034
Autor:
Pavel P. Solodkov, Olga Y. Volkova, Alexander Yu. Alekseyev, Anton N. Chikaev, Alexander Shestopalov, G. M. Yusubalieva, Alexander V. Taranin, Yulia V. Kononova, Sergey Guselnikov, Chikaev Na, Marina A. Gulyaeva, Andrey A. Gorchakov, Konstantin O Baranov, Tatyana N. Belovezhets, Tatiana V. Klypa, Vladimir P. Baklaushev, Vladimir T. Valuev-Elliston, Alexander M. Najakshin, Alexander G. Markhaev, Sergey V. Kulemzin, Alexander V. Ivanov, Victor F. Larichev, Ludmila V. Mechetina
Publikováno v:
Cell Discovery
Cell Discovery, Vol 7, Iss 1, Pp 1-15 (2021)
Cell Discovery, Vol 7, Iss 1, Pp 1-15 (2021)
In the absence of virus-targeting small-molecule drugs approved for the treatment and prevention of COVID-19, broadening the repertoire of potent SARS-CoV-2-neutralizing antibodies represents an important area of research in response to the ongoing p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46aa54d8440fb55b206445a517845af
https://pubmed.ncbi.nlm.nih.gov/34667147
https://pubmed.ncbi.nlm.nih.gov/34667147